Denali Therapeutics (DNLI) officer sells shares for RSU tax payment
Rhea-AI Filing Summary
Denali Therapeutics Inc. officer Alexander O. Schuth, the company’s COFO and Secretary, reported a sale of common stock. On 01/06/2026, he sold 17,218 shares of Denali common stock at $16.5 per share, with the filing stating that the sale was made to satisfy his tax obligations related to the settlement of previously vested restricted stock units (RSUs). After this transaction, he beneficially owned 282,828 shares directly, which the filing notes includes 141,100 unvested RSUs. The filing also reports 523,749 shares held indirectly through The Schuth Family Trust U/A DTD 06/05/2017, for which he serves as trustee.
Positive
- None.
Negative
- None.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 17,218 | $16.50 | $284K |
| holding | Common Stock | -- | -- | -- |
Footnotes (1)
- Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested RSUs. Includes 141,100 Unvested RSUs. The shares are held of record by The Schuth Family Trust U/A DTD 06/05/2017, for which the Reporting Person serves as trustee.
FAQ
What insider transaction did Alexander O. Schuth report for DNLI?
Alexander O. Schuth reported selling 17,218 shares of Denali Therapeutics Inc. common stock on 01/06/2026 at a price of $16.5 per share.
Does Alexander O. Schuth hold unvested RSUs in Denali Therapeutics (DNLI)?
Yes. The filing notes that his direct holdings of 282,828 shares include 141,100 unvested RSUs in Denali Therapeutics Inc.
What is Alexander O. Schuth’s role at Denali Therapeutics Inc. (DNLI)?
He is identified as an officer of Denali Therapeutics Inc., with the title COFO and Secretary, in the Form 4.